Intervention Protocol

Atomoxetine for schizophrenia

  1. Muhammad Shahzad Ashraf1,*,
  2. Zunaira Javed2,
  3. Ajit Kumar3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 27 MAR 2014

DOI: 10.1002/14651858.CD011035

How to Cite

Shahzad Ashraf M, Javed Z, Kumar A. Atomoxetine for schizophrenia (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD011035. DOI: 10.1002/14651858.CD011035.

Author Information

  1. 1

    Leeds York Partnership Foundation Trust, Psychiatry, Leeds, UK

  2. 2

    Hull and East Yorkshire Hospitals NHS Trust, Hull, UK

  3. 3

    South West Yorkshire Partnership NHS Foundation Trust, Psychiatry, Wakefield, UK

*Muhammad Shahzad Ashraf, Psychiatry, Leeds York Partnership Foundation Trust, Aire Court Community Unit, Lingwell Grove, Middleton, Leeds, LS10 4BS, UK.

Publication History

  1. Publication Status: New
  2. Published Online: 27 MAR 2014


Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.

Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.